CHESTER, NJ -- (MARKET WIRE) -- December 12, 2006 -- Molecular Biometrics, a privately held metabolomics company, today announced the completion of a licensing agreement with McGill University, Montreal, Canada, that secures a broad patent portfolio for the company's metabolomics technology platform. The Company also announced that it is expediting the development of its lead indication of embryo selection for in-vitro fertilization (IVF) and plans to enter into a pivotal U.S. clinical trial early in 2007.
